Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Halogenated hydrocarbon doai
Patent
1996-04-17
1999-02-09
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Halogenated hydrocarbon doai
514743, 514759, 514832, 514833, 424718, 424673, A01N 2902
Patent
active
058695397
ABSTRACT:
The present invention involves perfluoro compound emulsions including nitric oxide, their preparation and their use. These emulsions provide a new source of nitric oxide. Such nitric oxide-containing emulsions may be used for the administration of nitric oxide to individuals in need thereof. Individuals in need of nitric oxide administration can include those suffering from hypertension, preeclampsia and a number of other situations where an increased blood flow, for example, is desirable. In addition, given the long use of perfluoro compound emulsions as blood substitutes, the present invention provides a relatively safe mode for administering and distributing nitric oxide-without potential negative side effects such as toxicities due to drug metabolites.
REFERENCES:
patent: 5498421 (1996-03-01), Grinstaff et al.
Abdalla, Hossam I., MD, ChB, et al., "Prevention of Bone Mineral Loss is Postmenopausal Women by Norethisterone", Obstetrics and Gynecology, vol. 66, No. 6, pp. 789-792, Dec. 1985.
Ahokas, Robert A., et al., "Enhanced Endothelium-Derived Relaxing Factor Activity in Pregnant Spontaneously Hypertensive Rats", Suppl to Am J Obstet Gynecol, Part 2, vol. 164, No. 1, p. 242, 1991.
Alam, A.S.M. Towhidul, et al., "A Hypothesis for the Local Control of Osteoclast Function by Ca.sup.2+, Nitric Oxide and Free Radicals", Bioscience Reports, vol. 12, No. 5, pp. 369-380, 1992.
Bredt, David S. and Snyder, Soloman H., "Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme", Proc. Natl. Acad. Sci. USA, vol. 87, pp. 682-685, Jan. 1990.
Clark, Jr., Leland C. and Gollan, Frank, "Survival of Mammals Breathing Organic Liquid Equilibriated with Oxygen at Atmospheric Pressure", Science, vol. 152, pp. 1755-1756, Jun. 24, 1966.
Clark, Jr., Leland C. and Shaw, Robert F., "Stable emulsions of highly fluorinated organic compounds for preparation of artificial blood formulations", Chemical Abstracts, vol. 107:242588t, 1987.
Erner, William E., "Preparation of fluorinated triethylenediamines for an oxygen transport agent and blood-substitute emulsion containing them", Chemical Abstracts, vol. 113:138569a, No. 16, 1990.
Furchgott, Robert F. and Zawadzki, John V., "The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine", Nature, vol. 288, pp. 373-376, Nov. 1980.
Geyer, Robert P., Ph.D., "Fluorocarbon-Polyol Artificial Blood Substitutes", Seminars in Medicine of the Beth Israel Hospital Boston, vol. 289, No. 20, pp. 1077-1082, Nov. 15, 1973.
Ignarro, Louis J., "Signal Transduction Mechanisms Involving Nitric Oxide", Biochemical Pharmacology, vol. 41, No. 4, pp. 485-490, 1991.
Izumi, Hidetaka, MD, PhD, et al., "Gestational changes in L-arginine-induced relaxation of pregnant rat and human myometrial smooth muscle", Am J. Obstet Gynecol, vol. 169, No. 5, pp. 1327-1337, Nov. 1993.
Kasten, Thomas P., et al., "Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase", Proc. Natl. Acad. Sci. USA, vol. 91, pp. 3569-3573, Apr. 1994.
Kaufman, Robert J. and Richard, Thomas J., "Emulsions of highly fluorinated organic compounds as blood substitutes", Chemical Abstracts, vol. 113:46356a, 1990.
Lees, Christoph, et al., "Arrest of preterm labour and prolongation of gestation with glyceryl tinitrate, a nitric oxide donor", The Lancet, vol. 343, pp. 1325-1326, May 28, 1994.
Lowik, Clemens W.G.M., et al. "Inducible Production Nitric Oxide in Osteoblast-like Cells and in Fetal Mouse Bone Explants Is Associated with Suppression of Osteoclastic Bone Resorption", J. Clin. Invest., vol. 93, pp. 1465-1472, Apr. 1994.
MacIntyre, Iain, et al., "Osteoclastic inhibition: An action of nitric oxide not mediated by cyclic GMP", Proc. Natl. Acad. Sci. USA, vol. 88, pp. 2936-2940, Apr. 1991.
Molnar, Miklos, MD, and Hertelendy, Frank, PhD, DSc, "N.omega.-Nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents", Am J. Obstet Gynecol, vol. 166, No. 5, pp. 1560-1567, May 1992.
Moncada, S., et al., "Nitric Oxide: Physiology, Pathophysiology, and Pharmacology", Pharmacological Reviews, vol. 43, No. 2, pp. 109-172, Feb. 1991.
Pinto, Aldo, PhD, et al., "Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension", Am J. Obstet Gynecol, vol. 164, No. 2, pp. 507-513, Feb. 1991.
Riess, Jean G. and LeBlanc, Maurice, "Preparation of perfluorochemical emulsions for biomedical use: principles, materials and methods", Blood Substitutes, Ch. 5, pp. 94-129, 1988.
Riess, Jean G. and LeBlanc, Maurice, "Solubility and Transport Phenomena in Perfluorochemicals Relevant to Blood Substitution and Other Biomedical Applications", Pure & Appl. Chem., vol. 54, No. 12, pp. 2383-2406, 1982.
Riess, Jean G., "Highly fluorinated systems for oxygen transport, diagnosis and drug delivery", Colloids and Surfaces A: Physiochemical and Engineering Aspects, 84:33-48, 1994.
Riess, J. G., "The Design and Development of Improved Fluorocarbon-Based Products for Use in Medicine and Biology", Art. Cells, Blood Subs., and Immob. Biotech., 22(2), pp. 215-234, 1994.
Roberts, James M., MD, et al., "Preeclampsia: An endothelial cells disorder", Am J. Obstet Gynecol, vol. 161, No. 5, pp. 1200-1204, Nov. 1989.
Schweighardt, Frank Kenneth and Kayhart, Charles Randall, European Patent Application No. EP 282,949, filed on Sep. 21, 1988, with U.S. Patent Application No. 28,521, filed on Mar. 20, 1987, Chem. Abstr., 110:199223 and 199180, 1989.
Sloviter, Henry A. and Kamimoto, Toshiharu, "Erythrocyte Substitute for Perfusion of Brain", Nature, vol. 216, pp. 458-460, Nov. 4, 1967.
Venema, Richard C., et al., "Organization of the bovine gene encoding the endothelial nitric oxide synthase", Biochimica et Biophysica Acta, vol. 1218, pp. 413-320, 1994.
Weiner, Carl P., et al., "Induction of calcium-dependent nitric oxide synthase by sex hormones", Proc. Natl. Acad. Sci. USA, vol. 91, pp. 5212-5216, May 1994.
Yallampalli, Chandrasekhar, DVM, PhD, and Garfield, Robert E., PhD, "Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia", Am J. Obstet Gynecol, vol. 169, No. 5, pp. 1316-1320, Nov. 1993.
Yallampalli, Chandrasekhar, DVM, PhD, et al., "An L-arginine-intric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy", Am J. Obstet Gynecol, vol. 170, No. 1, Part 1, pp. 175-185, Jan. 1994.
Balaban A. T.
Garfield R. E.
Seitz W. A.
Board of Regents , The University of Texas System
Cintins Marianne M.
Jones Dwayne C.
The Texas A&M University System
LandOfFree
Emulsions of perfluoro compounds as solvents for nitric oxide (N does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Emulsions of perfluoro compounds as solvents for nitric oxide (N, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Emulsions of perfluoro compounds as solvents for nitric oxide (N will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1948817